The Senior Manager, Early Commercial Rheumatology, GI, and Neurology is part of Pfizer’s Inflammation & Immunology (I&I) Early Commercial Business within Global Commercial Strategy and reports to the I&I Disease Area Lead. The role contributes to long-range commercial strategy, disease-area portfolio prioritization, early commercial assessments, and investment decision support across Rheumatology, GI, and Neurology. It helps translate portfolio ambitions into disease-area strategies, disciplined portfolio choices, and integrated commercial plans focused on patient impact and enterprise value. The position serves as the asset-level commercial voice for assigned disease areas, applying scientific depth, commercial judgment, and an enterprise perspective to early development choices, product concepts, external innovation, and future value creation. The role works closely with R&D, Medical Affairs, Global Access Strategy & Pricing, Business Analytics & Insights, Competitive Intelligence, Business Development, and U.S. and international commercial teams. It requires working through ambiguity, influencing senior cross-functional stakeholders, advancing portfolio trade-offs and long-range planning, and supporting AI-enabled ways of working. Responsibilities include supporting disease-area strategy and long-range planning; informing portfolio prioritization and investment decisions; leading early commercial assessments and product concept development; providing commercial input to external innovation and Business Development assessments; building cross-functional alignment and team capabilities; and promoting responsible AI-enabled approaches to portfolio strategy and decision support.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior